Francesca Rini

1.8k total citations
26 papers, 1.0k citations indexed

About

Francesca Rini is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Francesca Rini has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 14 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Francesca Rini's work include Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immune Cell Function and Interaction (6 papers). Francesca Rini is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immune Cell Function and Interaction (6 papers). Francesca Rini collaborates with scholars based in Italy, United States and Argentina. Francesca Rini's co-authors include Chiara Castelli, Licia Rivoltini, Giorgio Parmiani, Filiberto Belli, Chiara Casati, Arabella Mazzocchi, Chiara Camisaschi, Frédéric Triebel, Michela Perego and Annamaria De Filippo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Francesca Rini

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Rini Italy 17 733 478 388 89 81 26 1.0k
Sophie Lebel‐Binay France 17 435 0.6× 279 0.6× 343 0.9× 98 1.1× 55 0.7× 21 977
Liza W.J. Toonen Netherlands 12 683 0.9× 473 1.0× 192 0.5× 57 0.6× 58 0.7× 12 976
Briana G. Nixon United States 15 563 0.8× 520 1.1× 502 1.3× 210 2.4× 84 1.0× 18 1.3k
Rena Morita Japan 15 303 0.4× 577 1.2× 429 1.1× 63 0.7× 75 0.9× 36 943
Lazar Vujanović United States 19 648 0.9× 588 1.2× 318 0.8× 85 1.0× 57 0.7× 39 1.1k
Juliane S. Walz Germany 16 453 0.6× 385 0.8× 349 0.9× 42 0.5× 115 1.4× 70 923
Julius Juaréz Australia 14 474 0.6× 381 0.8× 231 0.6× 55 0.6× 62 0.8× 19 991
Arabella Mazzocchi Italy 18 1.1k 1.4× 498 1.0× 489 1.3× 31 0.3× 76 0.9× 44 1.3k
Lorenzo F. Fanchi Netherlands 11 592 0.8× 725 1.5× 222 0.6× 76 0.9× 65 0.8× 17 1.1k
Carolina I. Domaica Argentina 19 1.0k 1.4× 424 0.9× 281 0.7× 42 0.5× 67 0.8× 25 1.2k

Countries citing papers authored by Francesca Rini

Since Specialization
Citations

This map shows the geographic impact of Francesca Rini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Rini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Rini more than expected).

Fields of papers citing papers by Francesca Rini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Rini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Rini. The network helps show where Francesca Rini may publish in the future.

Co-authorship network of co-authors of Francesca Rini

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Rini. A scholar is included among the top collaborators of Francesca Rini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Rini. Francesca Rini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Petta, Salvatore, Francesca Rini, Vincenza Calvaruso, et al.. (2019). Aminopyrine breath test predicts liver‐related events and death in HCV‐related cirrhosis on SVR after DAA therapy. Liver International. 40(3). 530–538. 1 indexed citations
4.
Camisaschi, Chiara, Salvatore Lorenzo Renne, Francesca Rini, et al.. (2018). Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients. BMC Cancer. 18(1). 983–983. 20 indexed citations
5.
Tuccitto, Alessandra, et al.. (2017). Melanoma Stem Cell Sphere Formation Assay. BIO-PROTOCOL. 7(8). e2233–e2233. 6 indexed citations
6.
Tazzari, Marcella, Valentina Indio, Barbara Vergani, et al.. (2016). Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment. Journal of Investigative Dermatology. 137(2). 484–493. 29 indexed citations
7.
Tuccitto, Alessandra, Marcella Tazzari, Francesca Rini, et al.. (2016). Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells. Stem Cells. 34(10). 2449–2460. 18 indexed citations
8.
Tazzari, Marcella, Elena Palassini, Barbara Vergani, et al.. (2015). Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report. BMC Cancer. 15(1). 58–58. 17 indexed citations
9.
Tazzari, Marcella, Tiziana Negri, Francesca Rini, et al.. (2014). Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy. British Journal of Cancer. 111(7). 1350–1362. 23 indexed citations
10.
Camisaschi, Chiara, Francesca Rini, Marcella Tazzari, et al.. (2013). LAG-3 expression and role in human pDC biology. Frontiers in Immunology. 4. 1 indexed citations
11.
Camisaschi, Chiara, Chiara Casati, Francesca Rini, et al.. (2010). LAG-3 Expression Defines a Subset of CD4+CD25highFoxp3+ Regulatory T Cells That Are Expanded at Tumor Sites. The Journal of Immunology. 184(11). 6545–6551. 271 indexed citations
12.
Casati, Chiara, Chiara Camisaschi, Francesca Rini, et al.. (2006). Soluble Human LAG-3 Molecule Amplifies the In vitro Generation of Type 1 Tumor-Specific Immunity. Cancer Research. 66(8). 4450–4460. 60 indexed citations
13.
Castelli, Chiara, Licia Rivoltini, Francesca Rini, et al.. (2004). Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer. Cancer Immunology Immunotherapy. 53(3). 227–233. 92 indexed citations
14.
Novellino, Luisa, Nicolina Renkvist, Francesca Rini, et al.. (2003). Identification of a Mutated Receptor-Like Protein Tyrosine Phosphatase κ as a Novel, Class II HLA-Restricted Melanoma Antigen. The Journal of Immunology. 170(12). 6363–6370. 38 indexed citations
15.
Castelli, Chiara, Francesca Rini, Licia Rivoltini, et al.. (2001). Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells.. PubMed. 61(1). 222–7. 144 indexed citations
16.
Bremers, Andreas J. A., Salvatore Andreola, Ermanno Leo, et al.. (2000). T cell responses in colorectal cancer patients: Evidence for class II HLA-restricted recognition of shared tumor-associated antigens. International Journal of Cancer. 88(6). 956–961. 17 indexed citations
17.
Castelli, Chiara, Paolo Tarsini, Arabella Mazzocchi, et al.. (1999). Novel HLA-Cw8-Restricted T Cell Epitopes Derived from Tyrosinase-Related Protein-2 and gp100 Melanoma Antigens. The Journal of Immunology. 162(3). 1739–1748. 38 indexed citations
18.
Castelli, Chiara, Arabella Mazzocchi, Francesca Rini, et al.. (1998). Immunogenicity of the ALLAVGATK (gp10017 – 25) peptide in HLA-A3.1 melanoma patients. European Journal of Immunology. 28(4). 1143–1154. 16 indexed citations
19.
Rivoltini, Licia, Douglas J. Loftus, Paola Squarcina, et al.. (1998). Recognition of Melanoma-Derived Antigens by CTL: Possible Mechanisms Involved in Down-Regulating Anti-Tumor T-Cell Reactivity. Critical Reviews in Immunology. 18(1-2). 55–63. 26 indexed citations
20.
Castelli, Chiara, Arabella Mazzocchi, Francesca Rini, et al.. (1998). Immunogenicity of the ALLAVGATK (gp1001725) peptide in HLA-A3.1 melanoma patients. European Journal of Immunology. 28(4). 1143–1154. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026